Novo Nordisk A/S (NVO)

125.24
-0.55(-0.44%)
Pre Market
125.74
+0.50(+0.40%)
- Real-time Data
  • Volume:
    900,055
  • Day's Range:
    124.82 - 126.58
  • 52 wk Range:
    91.51 - 127.79

NVO Overview

Prev. Close
125.79
Day's Range
124.82-126.58
Revenue
167.2B
Open
125.84
52 wk Range
91.51-127.79
EPS
23.24
Volume
900,055
Market Cap
284.45B
Dividend (Yield)
1.1381
(0.91%)
Average Volume (3m)
1,268,417
P/E Ratio
38.52
Beta
0.324
1-Year Change
13.69%
Shares Outstanding
2,259,260,747
Next Earnings Date
31 Jan 2023
What is your sentiment on Novo Nordisk ADR?
or
Market is currently closed. Voting is open during market hours.

Novo Nordisk A/S News

Novo Nordisk A/S Analysis

Novo Nordisk A/S Company Profile

Novo Nordisk A/S Company Profile

Employees
52696

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Read More

Analyst Price Target

Average931.67 (+643.91% Upside)
High1,042.14
Low769.58
Price125.24
No. of Analysts5
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyBuyBuyStrong Buy
Technical IndicatorsStrong BuyBuyStrong SellStrong BuyStrong Buy
SummaryStrong BuyBuyNeutralStrong BuyStrong Buy